Illumina cuts annual profit forecast for second straight quarter…
Shares of Illumina Inc. ILMN fell after hours on Thursday after the maker of DNA-sequencing technology cut its full-year sales…
Illumina plunges 8% on Q3 revenue miss & disappointing guidance…
…
Die Aktie von Illumina zählt heute zu den großen Verlierern an der Börse. Der Titel verliert deutlich an Wert. Zu…
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Nanopore Sequencing Market 2018-2028" report has been added to…
The Global Hereditary Testing Market Size was valued at USD 6.20 Billion in 2022 and the Worldwide Hereditary Testing Market…
…
TORONTO and NEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- illumin (TSX: ILLM, OTC: ILLMF) (“illumin” or “Company”),…
Die Aktie von Illumina zählt heute zu den großen Verlierern an der Börse. Der Titel verbilligt sich am Mittwoch deutlich.…
Activist-investor Carl Icahn said his firm had sued current and former board directors at Illumina concerning the acquisition of gene-sequencing…
Activist Icahn sues Illumina board over Grail acquisition - FT…
…
Illumina to divest Grail within a year if it does not win challenge in EU court…
Illumina Inc. ILMN responded Friday to an order it received Thursday from the European Commission directing the company to…
Die Aktie von Illumina zählt am Donnerstag zu den großen Verlierern an der Börse. Das Wertpapier verliert deutlich an Wert.…
EU antitrust regulators order Illumina to sell Grail…
…
U.S. genetic testing company Illumina has been ordered by EU antitrust regulators to sell cancer test maker Grail after it…
Illumina ordered by EU antitrust regulators to sell Grail…
…
Illumina to divest Grail if it loses final court appeals in US or EU…
*VILLEROY/EZB: DIE ZINSSÄTZE SIND JETZT AUF DEM RICHTIGEN NIVEAUROG SW - Roche erzielt mit Augenmittel Vabysmo weiteren Behandlungserfolg ILLUMINA -…
EU regulators to order Illumina to sell Grail - Financial Times…
…
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…
London (www.aktiencheck.de) - Rating-Update:
Die HSBC stuft die Aktie von Illumina Inc. (ISIN: US4523271090, WKN: 927079, Ticker-Symbol: ILU, NASDAQ-Symbol: ILMN) unverändert…
Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- The "Global Epigenomics Market Report and Forecast 2023-2031" report has been…
Prominent single-cell omics market players include 10x Genomics, Inc., Becton, Dickinson and Company (BD), CELLENION, PerkinElmer Inc., ANGLE plc, Illumina,…
…
NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress…
Grund zur Freude haben Aktionäre von Illumina : Der Kurs der Aktie legt kräftig zu. Eine Steigerung um 4,12 Prozent…
Illuminas future is looking a bit dim at the moment....…
Minneapolis (www.aktiencheck.de) - Rating-Update:
Piper Sandler bestätigt das Rating "overweight" für die Aktie von Illumina Inc. (ISIN: US4523271090, WKN: 927079, Ticker-Symbol:…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Illuminas acquisition of cancer test developer Grail has also faced heavy scrutiny from antitrust regulators in the U.S. and European…
...(Adds shares in paragraph 3)
Aug 11 (Reuters) - The U.S. Securities......…
...(Reuters) - The U.S. Securities and Exchange Commission (SEC) has......…
Illumina (ILMN) shipped 109 NovaSeq X instruments in the second quarter, boosting its supply capacity to more than 390 instruments…
Citi analyst Patrick Donnelly cut his price target on Illumina to $150 from $180....…
While the top- and bottom-line numbers for Illumina (ILMN) give a sense of how the business performed in the quarter…
...
in paragraph 6, 7 and 10)
Aug 9 (Reuters) - Illumina Inc cut annual
profit......…
Illumina 2Q Loss Narrows on Higher Sales of NovaSeq X Instruments...…
Shares of Illumina Inc. slid 6.6% after hours on Wednesday after the DNA-sequencing company tempered its full-year sales outlook, amid…
Illumina Medical Chief Phil Febbo, Chief Technology Officer Aravanis Exit...…
Illumina Reduces Guidance On Cautious Consumers...…
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
SAN DIEGO (dpa-AFX) - Below are the earnings highlights for Illumina Inc. (ILMN):Earnings: -$234 million in Q2 vs. -$535 million…
...Aug 9 (Reuters) - Illumina Inc lowered annual
profit forecast......…
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…